Dr. Alan Parsa, MD (he/him) is an Endocrinologist, Internist in Monterey, CA with over 13 years of experience. What is your opinion of Dr. Alan Parsa, MD? Rate this provider below so other people can make informed decision.
Over 13 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Alan Parsa, MD has received over $266,589 which includes payments from the following companies:
$98,901.42 from LILLY USA, LLC
$69,363.70 from Boehringer Ingelheim Pharmaceuticals, Inc.
$55,220.19 from AstraZeneca Pharmaceuticals LP
$19,367.56 from Novo Nordisk Inc
$15,042.90 from sanofi-aventis U.S. LLC
$1,414.96 from ELI LILLY AND COMPANY
$1,382.53 from Merck Sharp & Dohme Corporation
$1,300.14 from Medtronic MiniMed, Inc.
$681.17 from Amgen Inc.
$536.42 from INSULET CORPORATION
$443.61 from Radius Health, Inc.
$440.05 from Medtronic USA, Inc.
$426.26 from Regeneron Healthcare Solutions, Inc.
$344.90 from Corcept Therapeutics
$218.42 from GlaxoSmithKline, LLC.
$205.45 from Janssen Pharmaceuticals, Inc
$203.77 from Takeda Pharmaceuticals America, Inc.
$142.56 from Amarin Pharma Inc.
$138.48 from Dexcom, Inc.
$131.81 from Chiesi USA, Inc.
Payments received by Dr. Alan Parsa, MD were from the following categories:
$188,978.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!